Join Us Live for a Discussion on Medicare, Democracy, and the Future of Health Care
This week, the Medicare Rights Center commented on a proposal from the Centers for Medicare and Medicaid Services (CMS) to test a prescription drug payment model designed to “address the increasingly expensive cost of drugs in Medicare Part D while preserving or enhancing Medicare beneficiaries’ quality of care.” Affordability Challenges […]
This week, Medicare Rights submitted comments in response to the 2027 Advance Notice from the Centers for Medicare & Medicaid Services (CMS). The Advance Notice is an annual document outlining how CMS plans to calculate some Medicare Advantage (MA) payments for the following year, including how the agency will calculate […]
Nearly 1 in 5 people with Medicare are also enrolled in Medicaid. For these dually eligible beneficiaries, Medicare acts as the primary insurer, with Medicaid filling in the gaps in many ways: providing secondary insurance and supplemental benefits, reducing cost sharing, or managing care coordination between the programs. But Medicare […]
Enrollment in Medicare Advantage (MA) has grown steadily over the past two decades and now accounts for more than half of all eligible beneficiaries. In the context of this shift, a new report from the AARP Public Policy Institute (PPI) examines why a strong Original Medicare (OM) program is critical for […]
On February 3, President Trump signed legislation funding most federal agencies through fiscal year 2026 (FY26), which ends September 30. The package includes key health care extenders and reforms, including Medicare telehealth flexibilities and support for low-income beneficiary outreach. It also largely protects Administration for Community Living (ACL) programs and […]
Recent KFF polling shows that concern about health care costs is high and rising for the public, with 66% saying they are worried about paying for insurance and care. Health Care Costs Are Biggest Financial Worry For those polled by KFF, affording health care was the highest financial worry, even […]
Last week, the Centers for Medicare and Medicaid Services (CMS) announced the selection of the group of 15 drugs for the third cycle of negotiations under the Medicare Drug Price Negotiation Program. This program, established by the Inflation Reduction Act (IRA), requires CMS to identify a number of drugs for […]
Each year, the Centers for Medicare & Medicaid Services (CMS) gives notice of how some Medicare Advantage (MA) payments will be calculated for the following year. CMS released the 2027 Advance Notice last week and, while it maintains some disappointing patterns, it contains an important proposal that would whittle away […]
